Dauncey MJ, Bicknell RJ: Nutrition and neurodevelopment: mechanisms of developmental dysfunction and disease later in life. Nutr Res Rev. 1999, 12: 231-253.
Dong WK, Greenough WT: Plasticity of nonneuronal brain tissue: roles in developmental disorders. Ment Retard Dev Disabil Res Rev. 2004, 10: 85-90.
Lee YS, Silva AJ: The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci. 2009, 10 (2): 126-140.
Tsanov M, Manahan-Vaughn D: Synaptic plasticity from visual cortex to hippocampus: systems integration in spatial information processing. Neuroscientist. 2008, 14 (6): 584-597.
Howland JG, Wang YT: Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res. 2008, 169: 145-158.
Hubbs-Tait L, Nation JR, Krebs NF, Bellinger DC: Neurotoxicants, micronutrients, and social environments. PSPI. 2005, 6 (3): 57-121.
Roman GC: Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. J Neurol Sci. 2007, 262: 15-26.
Morley JE, Gordon J, Hershman JM: Zinc deficiency, chronic starvation, and hypothalamic-pituitary-thyroid function. Am J Clin Nutr. 1980, 33 (8): 1767-70.
Ivaturi R, Kies C: Mineral balances in humans as affected by fructose, high-fructose corn syrup, and sucrose. Plant Foods for Hum Nutr. 1992, 42 (2): 143-151.
Ward NI, Soulsbury K, Zettel VH, Colquhoun ID, Bunday S, Barnes B: The influence of the chemical additive tartrazine on the zinc status of hyperactive children-a double-blind placebo-controlled study. J Nutr Med. 1990, 1: 51-57.
Ward NI: Assessment of chemical factors in relation to child hyperactivity. J Nutr Environ Med. 1997, 7: 333-342.
Neggers YH, Cutler GR, Action RT, Alvarej JA, Bonner JL, Goldenberg RL, Go RCP, Roseman JM: A positive association between maternal serum zinc concentration and birth weight. Am J Clin Nutr. 1990, 51: 678-684.
Scholl TO, Hediger ML, Schall JI, Fischer RL, Khoo CS: Low zinc intake during pregnancy:its association with preterm and very preterm delivery. Am J Epidemiol. 1993, 137 (10): 1115-1124.
Schendel D, Karapurkar Bhasin T: Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics. 2008, 121 (6): 1155-1164.
Sandstead HH: Causes of zinc and iron deficiencies and their effects on the brain. J Nutr. 2000, 130: 347-349.
Chapman L, Chan HM: The influence of nutrition on methylmercury intoxication. Environ Health Perspect. 2000, 108 (Suppl 1): 29-56.
Clarkson TW, Strain JJ: Nutritional factors may modify the toxic action of methylmercury in fish-eating populations. J Nutr. 2003, 133 (Suppl 1): 1539-1543.
Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT: Effects of micronutrients on metal toxicity. Environ Health Perspect. 1998, 106 (Suppl 1): 203-216.
Institute for Children's Environmental Health. [http://www.iceh.org/pdfs/LDDI/LDDIStatement.pdf]
Palmer R, Blanchard S, Stein Z, Mandell D, Miller C: Environmental mercury release, special education rates, and autism disorder: an ecological study of texas. Health Place. 2006, 12: 203-209.
Palmer R, Blanchard S, Wood R: Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place. 2008
Environmental Protection Agency. [http://www.epa.gov/mercury/control_emissions/global.htm]
Environmental Protection Agency, Office of Superfund Remediation and Technology Innovation. [http://www.epa.gov/tio/download/remed/542r07003.pdf]
Bravo AG, Loizeau JL, Ancey L, Ungureanu VG, Dominik J: Historical record of mercury contamination in sediments. Environ Sci Pollut Res Int. 2008, 16 (1): 66-75. [http://www.springerlink.com/content/6x667718u2355515/fulltext.pdf]
Neculita CM, Zagury GJ, Deschenes L: Mercury speciation in highly contaminated soils from chlor-alkali plants using chemical extractions. J Environ Qual. 2005, 34: 255-262.
Environmental Protection Agency. [http://www.epa.gov/ord/NRMRL/pubs/600r02104/600r02104chap3.pdf]
Chlorine Institute. [http://www.chlorineinstitute.org/files/PDFs/EPA_2005_Annual_Report_Final.pdf]
Chlorine Institute. [http://www.chlorineinstitute.org/Stewardship/AboutChlorine.cfm?navItemNumber=3495]
United States International Trade Commission. [http://www.usitc.gov/]
Van Loon JC: Agricultural use of sewage treatment plant sludges, a potential source of mercury contamination. Environ Lett. 1973, 4: 259-265.
Chen C, Yu H, Zhao J, Li B, Qu L, Liu S, Zhang P, Chai Z: The roles of serum selenium and selenoproteins on mercury toxicity in environmental and occupational exposure. Environ Health Perspect. 2006, 114 (2): 297-301.
Goldman LR, Shannon MW: American academy of pediatrics technical report: mercury in the environment: implications for pediatricians. Pediatrics. 2001, 108 (1): 197-205.
World Health Organization. [http://www.inchem.org/documents/ehc/ehc/ehc101.htm]
Food and Drug Administration. [http://www.cfsan.fda.gov/~frf/sea-mehg.html]
McDowell MA, Dillon CF, Osterloh J, Bolger PM, Pellizzari E, Fernando R, Montes de Oca R, Schober SE, Sinks T, Jones RL, Mahaffey KR: Hair mercury levels in U.S. children and women of childbearing age: reference range data from NHANES 1999-2000. Environ Health Perspect. 2004, 112 (11): 1165-1171.
Hightower J, O'Hare A, Hernandez G: Blood mercury reporting in NHANES: identifying asian, pacific islander, native american, and multiracial groups. Environ Health Perspect. 2006, 114 (2): 173-175.
Mahaffey KR, Clickner RP, Bodurow CC: Blood organic mercury and dietary mercury intake national health and nutrition examination survey, 1999 and 2000. Environ Health Perspect. 2004, 112 (5): 562-570.
Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, Murata K, Sorensen N, Dahl R, Jorgensen PJ: Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997, 19: 417-428.
Davidson PW, Myers GJ, Cox C, Axtell C, Shamlaye C, Sloane-Reeves J, Cernichiari E, Needham L, Choi A, Wang Y, Berlin M, Clarkson TW: Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment outcomes at 66 months of age in the Seychelles Child Development Study. JAMA. 1998, 280: 701-707.
Raymond LJ, Ralston VC: Mercury: selenium interactions and health implications. Seychelles Medical and Dental Journal. 2004, 7 (Special 1): 72-77.
Julshamn K, Anderson A, Ringdal O, Morkore J: Trace elements intake in the faroe islands - element levels in edible parts of pilot whales (globicephalus meleanus). Sci Total Environ. 1987, 65: 53-62.
Lourdes MA, Culvin-Aralar A, Furness RW: Mercury and selenium interactions: a review. Ecotoxicol Environ Saf. 1991, 21: 348-364.
Ganther HE: Selenium: relation to decreased toxicity of methylmercury in diets containing tuna. Science. 1972, 175: 1122-1124.
Ohi G, Nishigaki S, Seki H, Tamura Y, Maki T: Efficacy of selenium in tuna and selenite in modifying methylmercury intoxication. Environ Res. 1976, 12: 49-58.
Spiers R, Spiers M: Proceedings of Clerc 2nd Annual Symposium: 24 October 1998. 1998, University of California at Davis
Vasconcellos M, Bode P, Paletti G: Determination of mercury and selenium in hair samples of brazilian Indian populations living in the amazon region by neutron activation analyses. Proceedings of the International Symposium on Trace Elements in Humans: New Perspectives, 3rd, 4-6 October 2001. Athens, Greece. 2001
Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, Rich-Edwards JW, Gillman MW: Maternal fish consumption, hair mercury, and infant cognition in a U.S. cohort. Environ Health Perspect. 2005, 113 (10): 1376-1380.
Association for Reproductive Health Professionals. [http://www.arhp.org/publications-and-resources/quick-reference-guide-for-clinicians/fish-and-health/summary]
Food and Drug Administration. [http://www.cfsan.fda.gov/~dms/admehg3.html]
Environmental Protection Agency. [http://www.epa.gov/waterscience/fish/advisories/2006/index.html]
Richardson AJ, Puri BK: A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26 (2): 233-239.
Corn Refiners Association. [http://www.corn.org/HFCSBrochure.pdf]
Lurgi Life Science GmbH: High fructose syrup production-process and economics. Proceedings of International Conference on Value-Added Products for the Sugar Industry. 1999, Baton Rouge, LA
Dufault R, LeBlanc B, Schnoll R, Cornett C, Schweitzer L, Wallinga D, Hightower J, Patrick L, Lukiw W: Mercury from chlor-alkali plants: measured concentrations in food product sugar. Environ Health. 2009, 8: 2-
United States Department of Agriculture. [http://www.ers.usda.gov/briefing/sugar/data/table52.xls]
Star Tribune. [http://www.startribune.com/lifestyle/health/38430359.html?elr=KArks7PYDiaK7DUvDE7aL_V_BD77:DiiUiacyKUnciaec8O7EyUr]
Newschaffer C, Falb M, Gurney J: National autism prevalence trends from united states special education data. Pediatrics. 2005, 115 (3): 277-282.
California Department of Developmental Services. [http://www.dds.ca.gov/AUTISM/docs/AutismReport_2007.pdf]
Lord C, Risi S, DiLavore PS, Shulman C, Thurm A, Pickles A: Autism from 2 to 9 years of age. Arch Gen Psychiatry. 2006, 63: 694-701.
Walsh WJ, Usman A, Tarpey J: Disordered metal metabolism in a large autism population. Proceedings of the Amer Psych Assn; New Research: Abstract NR109; May 2001; New Orleans, LA. 2001
Faber S, Zinn GM, Kern JC, Kingston HM: The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers. 2009, 14 (3): 171-180.
Blaylock RL: A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity. Altern Ther Health Med. 2009, 15 (1): 60-67.
Minami T, Miyata E, Sakamoto Y, Yamazaki H, Ichida S: Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thiomerosal injection. Cell Biol Toxicol. 2009,
Vruwink KG, Hurley LS, Gershwin ME, Keen CL: Gestational zinc deficiency amplifies the regulation of metallothionein induction in adult mice. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 1988, 188 (1): 30-34.
Geier D, Geier M: A prospective study of mercury toxicity biomarkers in autism spectrum disorders. J Toxicol EnvironHealth A. 2007, 70: 1723-1730.
Ladner L, Lindstrom L: Copper in society and the environment. 2nd revised edition. 1999, Environmental Research Group (MFG)
Olanow CW, Arendash GW: Metals and free radicals in neurodegeneration. Curr Opin Neurol. 1994, 7 (6): 548-558.
Konofal E, Lecendreux M, Arnulf I, Mouren MC: Iron deficiency in children with attention-deficity/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004, 158 (12): 1113-1115.
Starobrat-Hermelin B: The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin. 1998, 44: 297-314.
McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteus L, Prince E, Sonuga-Barke E, Warner JO, Stevenson J: Food additives and hyperactive behavior in 3-year-old and 8/9-year-old children in the community: a randomized, double-blinded placebo-controlled trial. Lancet. 2007, 370 (9598): 1560-1567.
McGee R, Prior M, Williams S, Smart D, Sanson A: The long-term significance of teacher-rated hyperactivity and reading ability in childhood: findings from two longitudinal studies. J Child Psychol Psychiatry. 2002, 43: 1004-1017.
Noseworthy MD, Bray TM: Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proc Soc Exp Biol Med. 2000, 223: 175-182.
Molteni R, Barnard R, Ying Z, Roberts K, Gomez-Pinilla F: A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002, 112 (4): 803-814.
Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, Suzuki K, Minabe Y, Takei N, Iyo M, Mori N: Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry. 2006, 30 (8): 1529-1531.
Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK: Increased levels of plasma brain-derived neurotrophic factor in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry. 2008, 32 (8): 1824-1828.
Kidd PM: Autism, an extreme challenge to integrative medicine. Part 1:the knowledge base. Altern Med Rev. 2002, 7 (4): 292-316.
James SJ, Melnyk S, Jernigan S: Low plasma methionine, cysteine, and glutathione levels are associated with increased frequency of common polymorphisms affecting methylation and glutathione pathways in children with autism. Experimental Biology Conference: 2 April 2005; San Diego. 2005
Reed DJ, Orrenius S: The role of methionine in glutathione biosynthesis by isolated rat hepatocytes. Biochem Biophys Res Commun. 1997, 77: 1257-1264.
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004, 80 (6): 1611-1617.
Almaguer-Melian W, Cruz-Aguado R, Bergado JA: Synaptic plasticity is impaired in rats with a low glutathione content. Synapse. 2000, 38: 369-374.
White AR, Cappai R: Neurotoxicity from glutathione depletion is dependent on extracellular trace copper. J Neurosci Res. 2003, 71: 889-897.
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973, 179: 588-590.
Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santocelli FM, Piemonte F: Protein glutathionylation in human central nervous system: potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res. 2006, 83 (2): 256-263.
Patrick L: Selenium biochemistry and cancer: a review of the literature. Altern Med Rev. 2004, 9 (3): 239-258.
Shanker G, Aschner JL, Syversen T, Aschner M: Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res. 2004, 128 (1): 48-57.
Makani S, Gollapudi S, Yel L, Chiplunkar S, Gupta S: Biochemical and molecular basis of thiomersal-induced apoptosis in t cells: a major role of mitochondrial pathway. Genes Immun. 2002, 3: 270-278.
Dringen R: Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000, 62: 649-671.
Sitta A, Barschak AG, Deon M, Barden AT, Biancini GB, Vargas PR, de Souza CF, Netto C, Wajner M, Vargas CR: Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int J Dev Neurosci. 2009, 27 (3): 243-247.
Brkljacic J, Milutinovic DV, Dundjerski J, Matic G: Mercury stimulates rat liver glucocorticoid receptor association with Hsp90 and Hsp70. J Biochem Mol Toxicol. 2004, 18 (5): 257-260.
De Moor JM, Kennette WA, Collins OM, Koropatnick J: Zinc-metallothionein levels are correlated with enhanced glucocorticoid responsiveness in mouse cells exposed to ZnCl2, HgCl2, and heat shock. Toxicol Sci. 2001, 64: 67-76.
Macho A, Hirsch T, Marzo I, Marchetti P, Dallaporta B, Susin SA, Zamzami N, Kroemer G: Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol. 1997, 158 (10): 4612-4619.
Patel R, McIntosh L, McLaughlin J, Brooke S, Nimon V, Sapolsky R: Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures. J Neurochem. 2002, 82: 118-125.
Coyle P, Philcox JC, Carey LC, Rofe AM: Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002, 59: 627-647.
Fraker PJ, King LE, Laakko T, Vollmer TL: The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000, 1399S-1406S. Suppl
Palmiter RD: The elusive function of metallothioneines. Proc Natl Acad Sci. 1998, 95: 8428-8430.
Simpkins CO: Metallothionein in human disease. Cell Mol Biol (Noisy-le-grand). 2000, 46 (2): 465-488.
Johnson S: The possible role of gradual accumulation of copper, cadmium, lead, and iron depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypotheses. 2000, 55 (3): 239-241.
Klaassen CD, Liu J: Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. J Toxicol Sci. 1998, 23: 97-102.
Park JD, Liu Y, Klaassen CD: Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology. 2001, 163 (2-3): 93-100.
Shimada A, Nagayama Y, Morita T, Yoshida M, Suzuki JS, Satoh M, Tohyama C: Localization and role of metallothioneins in the olfactory pathway after exposure to mercury vapor. Exp Toxicol Pathol. 2005, 57 (2): 117-125.
Syring RA, Hoexum Brouwer T, Bouwer M: Cloning and sequencing of cDNAs encoding for a novel copper-specific metallothionein and two cadmium-inducible metallothioneins from the blue-crab Callinectes sapidus. Comp Biochem Physiol C Toxicol Pharmacol. 2000, 125 (3): 325-332.
Choudhuri S, Kramer KK, Berman NE, Dalton TP, Andrews GK, Klaassen CD: Constitutive expression of metallothionein gene in mouse brain. Toxicol Appl Pharmacol. 1995, 131 (1): 144-154.
Chuah MI, Getchell ML: Metallothionein in olfactory mucosa of Alzheimer's disease patients and apoE-deficient mice. Neuroreport. 1999, 10 (9): 1919-1924.
Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE: Metallothionein III is reduced in Alzheimer's disease. Brain Res. 2001, 894 (1): 37-45.
Achner M: The functional significance of brain metallothioneins. FASEB J. 1996, 10: 1129-1136.
Miyazaki I, Asanuma M, Higashi Y, Sogawa CA, Tanaka K, Ogawa N: Age-related changes in expression of metallothionein-III in rat brain. Neurosci Res. 2002, 43: 323-333.
Shankar AH, Prasad AS: Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998, 68 (suppl): 447S-463S.
Sprietsma JE: Modern diets and diseases: NO-zinc balance, under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer. Med Hypotheses. 1999, 53 (1): 6-16.
Wainwright PE: Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc Nutr Soc. 2002, 61 (1): 61-69.
Hallahan B, Garland MR: Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leuko Essent Fatty Acids. 2004, 211-216.
Richardson A: The importance of omega 3 fatty acids for behaviour, cognition and mood. Scand J Food Nutri. 2003, 47 (2): 92-98.
Ottoboni F, Ottoboni A: Can attention deficit-hyperactivity disorder result from nutritional deficiency?. J Am Physicians Surg. 2003, 8 (2): 58-60.
Food and Drug Administration. [http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm154126.htm]
Lukiw WJ, Bazan NG: Docosahexaenoic acid and the aging brain. J Nutr. 2008, 138 (12): 2510-2514.
Lukiw WJ: Docosahexaenoic acid and amyloid-beta peptide signaling in Alzheimer's disease. World Rev Nutr Diet. 2009, 99: 55-70.
Wu A, Ying Z, Gomez-Pinilla F: Dietary omega-3 fatty acids normalize bdnf levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma. 2004, 21 (10): 1457-1467.
Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005, 115 (10): 2774-2783.
Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR: Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. J Clin Nutr. 1995, 62 (4): 761-768.
Mitchell EA, Aman MG, Turbott SH, Manku M: Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila). 1987, 26 (8): 406-411.
Colter AL, Cutler C, Meckling KA: Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case control study. Nutr J. 2008, 14 (7): 8-[http://www.nutritionj.com/content/pdf/1475-2891-7-8.pdf]
Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC: A randomized double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001, 139 (2): 189-196.
Hirayama S, Hamazaki T, Terasawa K: Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double blind study. Eur J Clin Nutr. 2003, 58: 467-473.
Richardson AJ, Montgomery P: The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005, 115 (5): 1360-1366.
Sorgi PJ, Hallowell EM, Hutchins HL, Sears B: Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J. 2007, 13 (6): 16-[http://www.nutritionj.com/content/pdf/1475-2891-6-16.pdf]
Sinn N, Bryan J: Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr. 2007, 28 (2): 82-91.
Johnson M, Ostlund S, Fransson G, Kadesjo B, Gillberg C: Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord. 2009, 12 (5): 394-401.
Belanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippe S, L'Heureux F, Ghadirian P, Vanasse CM, Levy E: Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009, 14 (2): 89-98.
Peet M: Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids. 2003, 69: 477-485.
Richardson AJ: Fatty acids in dyslexia, dyspraxia, ADHD and autistic spectrum. Nutri Prac. 2001, 3 (3): 18-24.
Arnold LE: Treatment alternatives for Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord. 1999, 3 (1): 30-48.
Burgess JR, Stevens L, Zhang W, Peck L: Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000, 71: 327S-330S.
Kozielec T, Starobrat-Hermelin B: Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res. 1997, 10 (2): 143-148.
Starobrat-Hermelin B, Kozielec T: The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD): postive response to magnesium oral loading test. Magnes Res. 1997, 10 (2): 149-156.
Galland L: Impaired essential fatty acid metabolism in latent tetany. Magnesium. 1985, 4: 333-338.
Mahfouz MM, Smith TL, Kummerow FA: Changes in linoleic acid metabolism and cellular phospholipid fatty acid composition in LLC-PK cells cultured at low magnesium concentrations. Biochim Biophys Acta. 1989, 1006 (1): 70-74.
Arnold LE, DiSilvestro RA: Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005, 15 (4): 619-627.
Bilici M, Yildirim F, Kandil S, Bekaroglu M, Yildirmis S, Deger O, Ulgen M, Yildiran A, Aksu H: Double-blind placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004, 28 (1): 181-190.
Guallar E, Sanz-Gallardo MI, Van't Veer P, Bode P, Aro A, Gomez-Aracena J, Kark JD, Riemersma RA, Martin-Moreno JM, Kok FJ, Heavy Metals and Myocardial Infarction Study Group: Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002, 347 (22): 1747-1754.
Innis SM, Palaty J, Vaghri Z, Lockitch G: Increased levels of mercury associated with high fish intakes among children from Vancouver, Canada. J Pediatr. 2006, 148 (6): 759-63.
United Kingdom Food Standards Agency. [http://www.food.gov.uk/multimedia/pdfs/fsis8005.pdf]
World Health Organization Joint Expert Committee on Food Additives. [http://whqlibdoc.who.int/trs/WHO_TRS_928.pdf]
United States Code of Federal Regulations. [http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=1070b19eb50e562daa872cfa1755aa09&rgn=div5&view=text&node=21:126.96.36.199.27&idno=21#21:188.8.131.52.184.108.40.206]
United Kingdom Food Standards Agency. [http://www.food.gov.uk/safereating/chemsafe/additivesbranch/colours/colourfree/]
Hughes JR: A review of recent reports on autism: 1000 studies published in 2007. Epilepsy Behav. 2008, 13 (3): 425-437.
Shahar E: Causal diagrams for encoding and evaluation of information bias. J Eval Clin Prac. 2009, 15 (3): 436-440.
Curtis LT, Patel K: Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med. 2008, 14 (1): 79-85.